Cheddar's Hena Doba and Brad Smith get into the latest.
Subscribe to the Need 2 Know newsletter here and listen to our morning podcast wherever you get your podcasts.
Share:
More In Business
Marvel's 'Eternals' Brings in $71 Million in U.S. Debut
Marvel's 'Eternals' blasted into theaters Friday, bringing in $71 million in its opening weekend, becoming the fourth-best debut of the year. It comes at a crucial time for the box office as theaters attempt to bring back customers after over a year of pandemic-induced lulls. Shawn Robbins, Chief Analyst with BoxofficePro.com joined Cheddar's Opening Bell to discuss the state of the U.S. box office and a return to theaters.
Virgin Orbit Partners With Japan To Bring Air Launch To Asia
Virgin Orbit is introducing air-launch services to the Eastern Hemisphere for the first time in history. Sir Richard Branson's space launch company has signed an agreement with ANA Holdings, the owners of Japan's largest airline, to procure 20 flights of its LauncherOne rocket from an airport in Japan, a big boost for the aerospace industry in Asia. Dan Hart, CEO of Virgin Orbit, joined Cheddar to discuss the new partnership, the future of air launch, and how small satellites can help monitor climate change impacts.
Morning Consult Releases U.S. Economic Outlook for November
Almost 2 years into the pandemic, supply chain woes continue to wreak havoc on our everyday lives. From groceries to chip shortages, both consumers and retailers are feeling the strain with prices only climbing as a result. Data intelligence company Morning Consult is out with its U.S. Economic Outlook for November revealing just how much of a threat these hold-ups could pose to the greater economic recovery. John Leer, Chief Economist at Morning Consult joined Cheddar's Opening Bell.
Economic Impact of Biden's $1.2 trillion Infrastructure Bill
After many years and at least two presidents hoping to overhaul America's infrastructure, congress finally came to an agreement. The House passed the bipartisan infrastructure bill late Friday, receiving thirteen republican votes but failing to earn votes from the six progressive squad members. Joseph Zeballos-Roig, Economics Reporter at Insider joined Cheddar's Opening Bell to discuss the economic impact of the bill.
Virgin Galactic Sees Surge in Space Flight Bookings, Raise Prices to $450K
Virgin Galactic is reporting an increase in demand for commercial space flights after seeing a boost in ticket sales, raising the price for a seat on a shuttle to $450,000. The company said they now have 700 customers.
Walmart Joins Forces With Gatik For Driverless Grocery Delivery
Walmart has joined forces with robotruck start-up Gatik to deploy driverless grocery delivery. We spoke to the CEO and co-founder of Gatik to discuss how the technology works and how autonomous vehicles will help ease supply chain issues.
Robinhood Data Breach Exposed Personal Information of 7 Million Customers
At least 7 million customers have been impacted by a data breach on the investing app Robinhood. The specific information that was leaked varied by each customer, but Robinhood stated that hackers did not access social security numbers or banking information.
Return of International Travelers to U.S. Could Give Needed Boost to Travel & Hospitality Sectors
Paulina Likos, Investing Reporter at US News & World report, joined Wake Up With Cheddar to break down how the U.S. reopening its borders to foreign travelers might provide a big boost to the hard-hit travel and tourism industry.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
